RIARIFY

This brand name is authorized in Austria, Estonia, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug RIARIFY contains a combination of these active pharmaceutical ingredients (APIs):

1 Formoterol fumarate dihydrate
UNII W34SHF8J2K - FORMOTEROL FUMARATE

Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge.

Read about Eformoterol
2 Glycopyrronium
UNII A14FB57V1D - GLYCOPYRRONIUM

Glycopyrronium is an inhaled long-acting muscarinic receptor antagonist (anticholinergic) for once-daily maintenance bronchodilator treatment of COPD. Glycopyrronium works by blocking the bronchoconstrictor action of acetylcholine on airway smooth muscle cells, thereby dilating the airways.

Read about Glycopyrronium
3 Beclometasone
UNII 5B307S63B2 - BECLOMETHASONE DIPROPIONATE

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.

Read about Beclometasone

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AL09 R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1771130, 1771141, 1771152, 1771163, 1771174
Country: IT Agenzia del Farmaco Identifier(s): 046480012, 046480024, 046480036, 046480048, 046480051
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1085533, 1085534, 1085536, 1085537, 1085538
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100405610

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.